Yuichi Nozaki

5.6k citations

78 papers · 3.2k indexed · h-index 33

Epidemiology top 1%
Endocrinology, Diabetes and Metabolism top 1%
Hepatology top 1%
Molecular Biology top 10%
Surgery top 5%

Co-authors: Atsushi Nakajima Masato Yoneda Koji Fujita Satoru Saito Hiroyuki Kirikoshi Masahiko Inamori Hirokazu Takahashi Kensuke Kubota
Topics: Liver Disease Diagnosis and Treatment (42 papers)Diet, Metabolism, and Disease (11 papers)Metabolism, Diabetes, and Cancer (9 papers)
Cited by: Hepatology Epidemiology Endocrinology, Diabetes and Metabolism
Journals: Nature Proceedings of the National Academy of Sciences Gastroenterology
Partner nations: Japan United States Italy

In The Last Decade

Yuichi Nozaki

71 papers receiving 3.2k citations

Peers

Countries citing papers authored by Yuichi Nozaki

Since Specialization

Citations

This map shows the geographic impact of Yuichi Nozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Nozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Nozaki more than expected).

Fields of papers citing papers by Yuichi Nozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Nozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Nozaki. The network helps show where Yuichi Nozaki may publish in the future.

Co-authorship network of co-authors of Yuichi Nozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Nozaki. A scholar is included among the top collaborators of Yuichi Nozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Nozaki. Yuichi Nozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic 2021 ·Life ·Yoshio Sumida,Masashi Yoneda,Katsutoshi Tokushige,Miwa Kawanaka,Hideki Fujii,Masato Yoneda,Kento Imajo,Hirokazu Takahashi,Yuichiro Eguchi,Masafumi Ono,Yuichi Nozaki,Hideyuki Hyogo,Masahiro Koseki,Yuichi Yoshida,Takumi Kawaguchi,Yoshihiro Kamada,Takeshi Okanoue,Atsushi Nakajima,(unknown)	39
2	Metabolic control analysis of hepatic glycogen synthesis in vivo 2020 ·Proceedings of the National Academy of Sciences ·Yuichi Nozaki,Max C. Petersen,Dongyan Zhang,Daniel F. Vatner,Rachel J. Perry,Abudukadier Abulizi,Sofie Hædersdal,Xian‐Man Zhang,Gina M. Butrico,Varman T. Samuel,Graeme F. Mason,Gary W. Cline,Kitt Falk Petersen,Douglas L. Rothman,Gerald I. Shulman	64
3	Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis 2020 ·International Journal of Molecular Sciences ·Yoshio Sumida,Masashi Yoneda,Katsutoshi Tokushige,Miwa Kawanaka,Hideki Fujii,Masato Yoneda,Kento Imajo,Hirokazu Takahashi,Yuichiro Eguchi,Masafumi Ono,Yuichi Nozaki,Hideyuki Hyogo,Masahiro Koseki,Yuichi Yoshida,Takumi Kawaguchi,Yoshihiro Kamada,Takeshi Okanoue,Atsushi Nakajima,(unknown)	50
4	Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis 2020 ·Nature ·Rachel J. Perry,Dongyan Zhang,Mateus T. Guerra,Allison L. Brill,Leigh Goedeke,Ali Nasiri,Aviva Rabin-Court,Yongliang Wang,Liang Peng,Sylvie Dufour,Ye Zhang,Xian‐Man Zhang,Gina M. Butrico,(unknown),Yuichi Nozaki,Gary W. Cline,Kitt Falk Petersen,Michael H. Nathanson,Barbara E. Ehrlich,Gerald I. Shulman	124
5	Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis 2013 ·PLoS ONE ·Yuji Ogawa,Kento Imajo,Masato Yoneda,Takaomi Kessoku,Wataru Tomeno,Yoshiyasu Shinohara,Shingo Kato,Hironori Mawatari,Yuichi Nozaki,Koji Fujita,Hiroyuki Kirikoshi,Shin Maeda,Satoru Saito,Koichiro Wada,Atsushi Nakajima	41
6	Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling 2012 ·Cell Metabolism ·Kento Imajo,Koji Fujita,Masato Yoneda,Yuichi Nozaki,Yuji Ogawa,Yoshiyasu Shinohara,Shingo Kato,Hironori Mawatari,Wataru Shibata,Hiroshi Kitani,Kenichi Ikejima,Hiroyuki Kirikoshi,Noriko Nakajima,Satoru Saito,Shiro Maeyama,Sumio Watanabe,Koichiro Wada,Atsushi Nakajima	283
7	Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study 2010 ·Hepatology Research ·Masato Yoneda,Koji Fujita,Yuichi Nozaki,Hiroki Endo,Hirokazu Takahashi,Kunihiro Hosono,Kaori Suzuki,Hironori Mawatari,Hiroyuki Kirikoshi,Masahiko Inamori,Satoru Saito,Tomoyuki Iwasaki,Yasuo Terauchi,Kensuke Kubota,Shiro Maeyama,Atsushi Nakajima	110
8	Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase 2010 ·Molecular Carcinogenesis ·Kunihiro Hosono,Hiroki Endo,Hirokazu Takahashi,Michiko Sugiyama,Takashi Uchiyama,Kaori Suzuki,Yuichi Nozaki,Kyoko Yoneda,Koji Fujita,Masato Yoneda,Masahiko Inamori,(unknown),Takeshi Chihara,Kan Shimpo,Hitoshi Nakagama,Atsushi Nakajima	151
9	Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b 2010 ·Journal of Viral Hepatitis ·Hironori Mawatari,Masato Yoneda,Koji Fujita,Yuichi Nozaki,(unknown),Hiroki Sasaki,Hiroshi Iida,Hideaki Takahashi,Masahiko Inamori,Yoshito Abe,Nobuaki Kobayashi,Kazumi Kubota,Hiroyuki Kirikoshi,Atsushi Nakajima,Satoru Saito	1
10	Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography 2010 ·Radiology ·Masato Yoneda,Kaori Suzuki,Shingo Kato,Koji Fujita,Yuichi Nozaki,Kunihiro Hosono,Satoru Saito,Atsushi Nakajima	286
11	Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values 2009 ·BMC Gastroenterology ·Hiroshi Iida,Masahiko Inamori,Yuichi Nozaki,Hiroki Endo,Kunihiro Hosono,Tomoyuki Akiyama,Yasunari Sakamoto,Hirokazu Takahashi,Tomoko Koide,Chikako Tokoro,Yasunobu Abe,(unknown)	6
12	Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions 2009 ·Gut ·Hideaki Endo,Kunihiro Hosono,Toshio Fujisawa,Hideaki Takahashi,M Sugiyama,Kyoko Yoneda,Yuichi Nozaki,Koji Fujita,Masato Yoneda,Masahiko Inamori,Koichiro Wada,Hitoshi Nakagama,Atsushi Nakajima	38
13	Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease 2009 ·Journal of Hepatology ·Yuichi Nozaki,Koji Fujita,Masato Yoneda,Koichiro Wada,Yoshiyasu Shinohara,Hirokazu Takahashi,Hiroyuki Kirikoshi,Masahiko Inamori,Kensuke Kubota,Satoru Saito,Tetsuya Mizoue,Naohiko Masaki,Yoji Nagashima,Yasuo Terauchi,Atsushi Nakajima	73
14	Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease 2008 ·Gut ·Koji Fujita,Yuichi Nozaki,Koichiro Wada,Masato Yoneda,Hideki Endo,Hirokazu Takahashi,Tomoyuki Iwasaki,Masahiko Inamori,Yoshito Abe,Noritoshi Kobayashi,Hiroyuki Kirikoshi,Kensuke Kubota,Satoru Saito,Yoji Nagashima,Atsushi Nakajima	106
15	Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH) 2008 ·BMC Gastroenterology ·Masato Yoneda,Takashi Uchiyama,Shingo Kato,Hiroki Endo,Koji Fujita,Kyoko Yoneda,Hironori Mawatari,Hiroshi Iida,Hirokazu Takahashi,Hiroyuki Kirikoshi,Masahiko Inamori,Yuichi Nozaki,Noritoshi Kobayashi,Kensuke Kubota,Satoru Saito,Shiro Maeyama,Mina Sagara,Hiroyuki Aburatani,Tatsuhiko Kodama,Atsushi Nakajima	72
16	5-Aminosalicylic Acid Given in the Remission Stage of Colitis Suppresses Colitis-Associated Cancer in a Mouse Colitis Model 2007 ·Clinical Cancer Research ·(unknown),Ayako Tomimoto,Koichiro Wada,Toshio Fujisawa,Koji Fujita,Kyoko Yonemitsu,Yuichi Nozaki,Hiroki Endo,Hirokazu Takahashi,Masato Yoneda,Masahiko Inamori,Kensuke Kubota,Satoru Saito,Yoji Nagashima,Hitoshi Nakagama,Atsushi Nakajima	36
17	Life Style-Related Diseases of the Digestive System: Gene Expression in Nonalcoholic Steatohepatitis Patients and Treatment Strategies 2007 ·Journal of Pharmacological Sciences ·Masato Yoneda,Hiroki Endo,Yuichi Nozaki,Ayako Tomimoto,Toshio Fujisawa,Koji Fujita,Kyoko Yoneda,Hirokazu Takahashi,Satoru Saito,Tomoyuki Iwasaki,Shogo Yamamoto,Shuichi Tsutsumi,Hiroyuki Aburatani,Koichiro Wada,Kikuko Hotta,Atsushi Nakajima	15
18	Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats 2007 ·Digestive Diseases and Sciences ·Koji Fujita,Masato Yoneda,Koichiro Wada,Hironori Mawatari,Hirokazu Takahashi,Hiroyuki Kirikoshi,Masahiko Inamori,Yuichi Nozaki,Shiro Maeyama,Satoru Saito,Tomoyuki Iwasaki,Yasuo Terauchi,Atsushi Nakajima	64
19	Hypoadiponectinemia Plays a Crucial Role in the Development of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus Independent of Visceral Adipose Tissue 2007 ·Alcoholism Clinical and Experimental Research ·Masato Yoneda,Tomoyuki Iwasaki,Koji Fujita,Hiroyuki Kirikoshi,Masahiko Inamori,Yuichi Nozaki,Shiro Maeyama,Koichiro Wada,Satoru Saito,Yasuo Terauchi,Atsushi Nakajima	35
20	Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients 2007 ·Journal of Viral Hepatitis ·Minoru Yoneda,(unknown),Tatsunori Ikeda,Koji Fujita,Hironori Mawatari,Hiroyuki Kirikoshi,Masahiko Inamori,Yuichi Nozaki,Takumi Akiyama,Hirokazu Takahashi,Yoshito Abe,Kazumi Kubota,(unknown),Yasuo Terauchi,Togo Shimozawa,Atsushi Nakajima	55

About Yuichi Nozaki

Yuichi Nozaki is a scholar working on Hepatology, Gastroenterology and Epidemiology, having authored 78 papers that have together received 3.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (42 papers), Diet, Metabolism, and Disease (11 papers) and Metabolism, Diabetes, and Cancer (9 papers). The work is most often cited by research in Hepatology (759 citations), Epidemiology (2.0k citations) and Endocrinology, Diabetes and Metabolism (902 citations). Yuichi Nozaki has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Atsushi Nakajima, Masato Yoneda, Koji Fujita, Satoru Saito, Hiroyuki Kirikoshi, Masahiko Inamori, Hirokazu Takahashi, Kensuke Kubota, Hironori Mawatari and Kunihiro Hosono. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact